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OBJECTIVES We sought to evaluate whether cellular mass changes (including apoptosis and proliferation)
after arterial injury could interact with restenosis and arterial remodeling.
BACKGROUND The mechanisms controlling arterial remodeling after angioplasty remain poorly understood.
Apoptosis and cell proliferation have been previously described after balloon angioplasty.
However, their importance in the occurrence of arterial remodeling and restenosis is
unknown.
METHODS Atherosclerosis was induced in 48 femoral arteries of New Zealand White rabbits by
air-desiccation and a high-cholesterol diet. One month later, angioplasty was performed in 40
arteries. Apoptosis, cell proliferation, residual stenosis and arterial remodeling were evaluated
at 2 h and 3, 7, 14, 21 and 28 days after angioplasty.
RESULTS Cell proliferation and apoptosis profiles were similar, but the peak in cell proliferation
occurred approximately four days earlier than the peak in apoptosis in the neointima and
media. Apoptosis density was positively correlated with arterial remodeling in the neointima
and media (r  0.69, p  0.005 and r  0.50, p  0.05, respectively). Moreover, residual
stenosis was inversely correlated with apoptosis density in the neointima and media (r 
0.62, p  0.008 and r  0.52, p  0.04, respectively). In contrast, cell proliferation was
independent of restenosis and arterial remodeling.
CONCLUSIONS In this model, cell proliferation preceded apoptosis throughout the four weeks after
angioplasty. Apoptosis was inversely correlated with restenosis. Interestingly, apoptosis was
also related to enlargement remodeling after balloon angioplasty. (J Am Coll Cardiol 2002;
39:1680–5) © 2002 by the American College of Cardiology Foundation
Restenosis remains the principal limitation of coronary
angioplasty (1). Neointimal hyperplasia was originally con-
sidered to be the primary mechanism of restenosis after
balloon angioplasty (2). However, antiproliferative therapies
have failed to prevent restenosis in humans (3). The
respective roles of neointimal hyperplasia and arterial re-
modeling were evaluated in various animal models of
restenosis (4,5). It has been shown that neointimal hyper-
plasia was independent of the severity of restenosis, whereas
constrictive remodeling was closely correlated with resteno-
sis after angioplasty. Interestingly, similar concepts were
shown to pertain to humans studied by intravascular ultra-
sonography (6,7).
Currently, little is known about the mechanisms control-
ling arterial remodeling after arterial injury. A better under-
standing could help to define new strategies. A cellular mass
at the arterial injury site depends on the balance between cell
death, including apoptosis, and cell proliferation. Although
apoptosis and cell proliferation have been extensively stud-
ied after balloon angioplasty, the relationships between
apoptosis, cell proliferation, arterial remodeling and reste-
nosis have not been evaluated (8–15). Moreover, this injury
model could give access to the information relative to the
healing process after plaque rupture. In humans, data on
apoptosis, cell proliferation and restenosis are discordant:
apoptosis and cell proliferation were either decreased or
increased in restenotic arteries, as compared with primary
atherosclerotic arteries (16–19). Because apoptosis and cell
proliferation of restenotic lesions cannot be compared with
non-restenotic arteries in humans, experimental models
must be used to evaluate this relationship. Our study was
designed to simultaneously evaluate the time courses of
apoptosis and cell proliferation, as well as their relationship
with arterial remodeling and restenosis after balloon angio-
plasty in an atherosclerotic femoral rabbit model.
METHODS
Animal model. The investigation conforms with the
“Guide for the Care and Use of Laboratory Animals,”
published by the National Institutes of Health (NIH pub-
lication no. 85-23, revised 1985).
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Atherosclerotic-like lesions were induced in New Zea-
land White rabbits (n  24) by the combination of
air-desiccation and a high-cholesterol diet, as previously
described (5).
Four weeks later, angioplasty was performed in 40 fem-
oral arteries. Eight arteries in four animals did not undergo
angioplasty, serving as the control group. A baseline ilio-
femoral angiogram was performed. After a bolus of 100 UI/kg
heparin, angioplasty consisted of three inflations at 6 atm
for 60 s, with an angioplasty balloon catheter (balloon/artery
ratio between 1.0 and 1.2). Angiography was performed
10 min after the last inflation and an intra-arterial injection
of nitrates (250 g) to minimize post-angioplasty spasm.
After angioplasty, a high-cholesterol diet was replaced by
normal rabbit chow.
Angiography was repeated before sacrifice—at 2 h (n 
4) and 3 (n  4), 7 (n  8), 14 (n  8), 21 (n  8) and
28 days (n  8) after angioplasty—and 8 weeks after
air-desiccation for nondilated arteries. Arteries were re-
trieved after in vivo fixation by 10% buffered formaldehyde
solution perfused at 100 mm Hg for 15 min.
Angiographic analysis. The minimal lumen diameter was
measured by two independent physicians using electronic
calipers, and the final results were obtained by averaging the
two separate measurements.
Histomorphometric analysis. Each femoral artery was cut
in serial sections (5 m) at sites 1 to 2 mm apart, from the
proximal to distal end, embedded in paraffin and stained
with orceine for morphometric analysis. Each artery was
evaluated at the lesion and reference sites, as previously
described (5).
“Residual stenosis” was defined as the difference between
the luminal areas of the reference and lesion sites, normal-
ized by the luminal area of the reference site. The “remod-
eling index” was defined as the ratio of the area circum-
scribed by the external elastic lamina of the lesion site to the
same area of the reference site. “Neointimal medial growth”
was defined as the difference between the area of intima plus
media at the lesion site and the proximal reference site,
normalized by the same area of the reference site.
Immunohistochemistry. Cell proliferation was detected
with a monoclonal rabbit antibody against human Ki-67
proliferation antigen (dilution of 1/50; Dako SA, Trappes,
France), after antigen retrieval by boiling in 10 mmol/liter
citrate buffer for 10 min (15). The sections were then
incubated with avidin and biotin horseradish peroxidase
complex for 30 min. The sections were stained with diami-
nobenzidine and counterstained with hematoxylin.
In situ detection of apoptotic cells was performed simul-
taneously with double-stranded labeled deoxyribonucleic
acid (DNA) fragments ligated to the DNA ends, terminal
deoxynucleotidyl transferase-mediated dUTP nick end-
labeling (TUNEL) and single-stranded DNA in paraffin-
embedded tissue samples, as previously described (20,21).
Briefly, double-stranded DNA fragments were prepared by
polymerase chain reaction with Taq polymerase, and
digoxigenin-labeled fragments were ligated to DNA in
tissue sections, using T4 DNA ligase (20). For the TUNEL
technique, the sections were pretreated with proteinase K
(20 g/ml) for 15 min. Endogenous peroxidase activity was
blocked with 3% H2O2. An apoptosis detection kit (Dako)
that included the chromagen diaminobenzidine was used.
For single-stranded DNA, the sections were stained with
Mab F7-26 (Apostain, Alexis, San Diego, California) with
the chromagen 3-amino-9-ethyl-carbazone.
Ribonucleic acid (RNA) splicing and DNA repair were
evaluated on adjacent sections, with mouse monoclonal
antibodies against the splicing factor (SC-35, dilution of
1/200; Sigma, Saint Louis, Missouri) and a poly(ADP-
ribose) polymerase-1 (PARP-1; dilution of 1/100; Pharm-
ingen, San Diego, California), as previously described
(22,23). Splicing of RNA was evaluated to improve the
specificity of the TUNEL technique (22). Single-stranded
DNA, TUNEL and T4 DNA ligase were combined with
PARP-1 detection, because this enzyme is known to be a
target of the caspase protease activity associated with apo-
ptosis (23).
For co-localization of apoptotic and proliferating cells
with specific cell type markers, immunostaining was per-
formed on arterial sections adjacent to those used for
apoptosis and cell proliferation (i.e., 5 m). Smooth muscle
cells (SMCs) and macrophages were detected by monoclo-
nal mouse anti-human alpha-smooth muscle actin (dilution
of 1/100; Dako) and monoclonal mouse anti-rabbit macro-
phages (RAM11, dilution of 1/50; Dako), respectively.
The specificity of the immunohistochemical reactions
was checked by omitting the primary antibody and substi-
tuting the antibody with an unrelated antibody at the same
concentration.
Quantification of apoptosis and cell proliferation.
Apoptosis and cell proliferation were manually identified in
the neointima, media and adventitia at100 magnification.
Apoptosis density was defined as the number of positive
nuclei by in situ DNA ligation at the lesion site, normalized
by the total number of nuclei at the lesion site. Cell
proliferation density was defined as the number of Ki-67–
positive nuclei at the lesion site, normalized by the total
number of nuclei at the lesion site.
Statistical analysis. Results are expressed as the mean
value  SD. Occluded arteries (n  3) were excluded from
the study. Correlations were evaluated by the Spearman
Abbreviations and Acronyms
DNA  deoxyribonucleic acid
PARP-1  poly (ADP-ribose) polymerase-1
SMC  smooth muscle cell
TUNEL  terminal deoxynucleotidyl transferase-
mediated dUTP nick end-labeling
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rank correlation test. The statistical threshold was set at p
0.05.
RESULTS
Apoptosis was quantified using the T4 DNA ligase tech-
nique, because the TUNEL technique was nonspecific, as
previously described (i.e., some cells stained positive by both
TUNEL and the proliferation marker Ki-67 or SC-35,
indicating false positivity, in contrast to T4 DNA ligase)
(Fig. 1) (22). Indeed, the stains with T4 DNA ligase,
single-stranded DNA or PARP-1 were very similar, which
was not always the case with TUNEL (Fig. 2).
Time courses of apoptosis and cell proliferation. The
apoptosis density was low in control arteries and dilated
arteries 2 h after angioplasty, at the levels of the neointima,
media and adventitia (Fig. 3A). The apoptosis density
reached a maximum at day 7 in the neointima and media,
remained high at 14 days, decreased by 21 days and returned
to baseline at 28 days (Fig. 3A). The apoptosis density
peaked earlier in the adventitia (day 3) and followed the
same decay until day 28 (Fig. 3A). The apoptosis density
was particularly high in SMCs, but was also increased in
macrophages (Table 1). The time courses of apoptosis in
SMCs and macrophages were similar (data not shown).
After angioplasty, cell proliferation was predominantly
detected in the neointima, but it also occurred in the media
and adventitia. Proliferation of SMCs reached a maximum
at three days and progressively returned to baseline (Fig.
3B). Cell proliferation was nearly undetectable in the
control arteries (Fig. 3B).
In the neointima and media, profiles of cell proliferation
and apoptosis were similar, but the peak in cell proliferation
occurred four days earlier than the peak in apoptosis. The
apoptosis density remained high for a longer period than did
cell proliferation. In contrast, apoptosis and cell prolifera-
tion were approximately synchronous in the adventitia.
Apoptosis, arterial remodeling and restenosis. Residual
stenosis (days 14 to 21) was inversely correlated with the
density of apoptosis in the neointima (r  0.62, p 
0.008) (Fig. 4A) and media (r  0.52, p  0.04) (Fig.
4B), but not in the adventitia (r  0.2, p  NS).
The apoptosis density was positively correlated with
Figure 1. Rabbit femoral artery 14 days after balloon angioplasty. (A) Macrophages (brown) revealed by monoclonal anti-rabbit macrophage (RAM11).
(B) Smooth muscle cells (brown) in the neointima and media, revealed by a monoclonal antibody against alpha-smooth muscle actin. (C) Apoptotic nuclei
(purple, arrowheads) in the neointima and media, using T4 deoxyribonucleic acid ligase. (D) Absence of detection of ribonucleic acid splicing, using
monoclonal antibody against SC-35. Magnification 40 (A to D). Counterstaining with hematoxylin (A and B).
Figure 2. In situ detection of apoptosis in the rabbit atherosclerotic femoral artery 14 days after balloon angioplasty. (A) Monoclonal antibody against poly
(ADP-ribose) polymerse-1 (red). (B) T4 deoxyribonucleic acid (DNA) ligase (purple). (C) Single-stranded DNA (red). (D) Terminal deoxynucleotidyl
transferase-mediated dUTP nick end-labeling (brown). Magnification 40 (A–D). Counterstaining with hematoxylin (D).
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arterial remodeling at the level of the neointima (r  0.69,
p  0.005) (Fig. 4C) and media (r  0.50, p  0.05) (Fig.
4D), but not in the adventitia (r  0.2, p  NS).
Cell proliferation, arterial remodeling and restenosis.
Residual stenosis was independent of cell proliferation in
the neointima (r  0.03, p  NS), media (r  0.2, p 
NS) and adventitia (r  0.14, p  NS). Cell proliferation
was independent of arterial remodeling after angioplasty at
each layer of the arterial wall (neointima: r  0.2, p  NS;
media: r  0.02, p  NS; adventitia: r  0.04, p  NS).
Arterial remodeling, neointimal medial growth and re-
stenosis. The minimal lumen diameter increased after
angioplasty (1.56 0.04 vs. 1.76 0.04 mm; p 0.01) and
decreased at 28 days (1.15  0.09 mm, p  0.01).
Arterial remodeling was undetectable before day 14, after
angioplasty. As expected, residual stenosis was correlated
with arterial remodeling (r  0.70, p  0.004), but was
independent of neointimal medial growth (r  0.16, p 
NS).
DISCUSSION
The purpose of this study was to evaluate the time courses
of apoptosis and cell proliferation, as well as the relation-
Figure 3. Bar graph representing apoptosis (A) and cell proliferation (B) at 2 h (n  4) and 3 (n  4), 7 (n  8), 14 (n  8), 21 (n  8) and 28 (n 
8) days after angioplasty in nondilated arteries (n  8), the neointima (solid bar), the media (hatched bar) and the adventitia (open bar). Results are
expressed as the mean value  SD.
Table 1. Quantification and Location of Apoptotic Smooth





Neointima 63.3  19.1 25.3  18.1
Media 67.1  18.8 16.7  9.3
Adventitia 0.0  0.0 11.7  10.0
Data are expressed as the mean value  SD. Apoptotic smooth muscle cells (SMCs)
and apoptotic macrophages were defined by the number of apoptotic SMCs or
macrophages, normalized by the total number of apoptotic cells.
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ships between apoptosis, cell proliferation, arterial remod-
eling and restenosis, after balloon angioplasty in the athero-
sclerotic rabbit model. We found that cell proliferation
preceded apoptosis throughout the four weeks after angio-
plasty. Furthermore, apoptosis, but not cell proliferation,
was associated with enlargement remodeling and the ab-
sence of restenosis.
Profiles of apoptosis and cell proliferation after angio-
plasty. The balance between SMC death and proliferation
determines the number of SMCs in the arterial wall after
balloon angioplasty. Their time courses after angioplasty
have been extensively evaluated in experimental models in
which dilation was often performed in normal arteries,
which cannot simulate dilation of existing atherosclerotic
plaque (8–15). We found that the SMC proliferation
profile was similar to those profiles previously found in
models with dilation of normal arteries (8,9). In contrast,
the profile of apoptosis differed. First, apoptosis was not
detected in the first hours after angioplasty, as previously
reported by Perlman et al. (12). Second, apoptosis was
detected in the neointima, media and adventitia after injury
(day 3), and it persisted subsequently (day 21).
Simultaneous evaluation of apoptosis and cell prolifera-
tion profiles showed that proliferation preceded apoptosis
throughout the four weeks after angioplasty, at the level of
the neointima and media. Further studies are needed to
evaluate the effect of antiproliferative therapies on the
occurrence of apoptosis.
Apoptosis, arterial remodeling and restenosis. The other
purpose of this study was to evaluate the relationship
between apoptosis and arterial remodeling after angioplasty,
because it has been shown that constrictive remodeling was
related to apoptosis in neonatal arteries and human athero-
sclerotic arteries (24,25). We found that apoptosis dramat-
ically increased in the neointima and media of arteries with
enlargement remodeling, as compared with those with
constrictive remodeling. Apoptosis was inversely correlated
with restenosis. In contrast, we did not find any relationship
between apoptosis and remodeling at the level of the
adventitia. This does not eliminate the possible role of
adventitial cells in the remodeling process, because it has
been reported that myofibroblasts proliferate and migrate
into the media and neointima, where apoptosis could occur
(26). We do not know whether apoptosis promotes enlarge-
ment remodeling. However, we reported that the collagen
content was significantly lower in arteries with enlargement
remodeling, as compared with those with constrictive re-
modeling (27). A loss of SMCs by apoptosis could lead to
a decreased synthesis of collagen.
Study limitations. As previously reported, RNA splicing
and cell proliferation reduces the specificity of the TUNEL
technique under our experimental conditions (22). In con-
Figure 4. Scattergrams of apoptosis in the neointima (A and C) and media (B and D) versus restenosis (A and B) and arterial remodeling (C and D).
Correlations were evaluated by the Spearman rank correlation test.
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trast, T4 DNA ligase and single-stranded DNA were more
specific for the detection of apoptosis and closely correlated
with PARP-1. Transmission electron microscopy and DNA
electrophoresis could not be used, because our tissue sam-
ples were needed for histomorphometric analysis to evaluate
arterial remodeling and apoptosis.
Restenosis has usually been evaluated in the atheroscle-
rotic rabbit model 28 days after balloon angioplasty (4,5).
However, we attempted to compare the levels of apoptosis
and cell proliferation with arterial remodeling and the
severity of restenosis at days 14 and 21, but not at day 28,
because apoptosis and cell proliferation were nearly unde-
tectable at day 28. Furthermore, we did not evaluate this
relationship at day 7, because restenosis and arterial remod-
eling did not occur yet.
In clinical practice, the majority of patients undergo
coronary stenting. However, 20% still undergo balloon
angioplasty, especially in small arteries (i.e., reference diam-
eter2.5 mm) in which the systematic benefit of stenting is
controversial. Therefore, our results are only applicable to
restenosis after balloon angioplasty.
Conclusions. Cell proliferation preceded apoptosis. Apo-
ptosis, but not cell proliferation, was associated with en-
largement remodeling and inversely correlated with reste-
nosis. These results raise questions related to whether
strategies aimed at enhancing apoptosis might promote
enlargement remodeling and prevent restenosis after angio-
plasty.
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